Introduction
Juvenile idiopathic arthritis (JIA) is a multifactor chronic inflammatory joints disease that is characterized by long progressive course leading to development of contractures and loss of joint´s function. Currently, there are only several laboratory and radiological predictors of unfavorable prognosis of JIA. In recent years, scientists studied the molecular basis of the development and maintenance of chronic inflammation in the joint. 
Objectives
Identify predicting factors of course and outcome of JIA in children by based on comprehensive analysis of the clinical and instrumental, laboratory and molecular genetic tests.
Methods
Clinical, serological, x-ray manifestations, ultrasound and MRI data were analyzed in 126 children with JIA. Three polymorphisms gene P53 were detected by PCR-RFLP. 60 healthy children without family history of any autoimmune disease were controls.
Results
We haven't revealed significant differences distribution genotypes of Arg72Pro ex4, ins/del16bp in3 and G13964C in6 gene P53 between children with JIA and controls. But girls with oligo-and polyarthritis with genotypes containing three or more minor polymorphic variant 72Pro, ins16bp, 13964C gene P53 in any combination were with more severe variant articular lesion. By means of ROC-curve analysis and regression methods were assessed the contribution of molecular genetic, clinical, instrumental and laboratory factors on the disease with a view to determine the prognostic significance of these factors. The presence of erosions of the joints and carrier of genotypes containing allele 72Pro gene P53 were found in girls with JIA like highly information signs of prognosis "active" arthritis and the presence of erosions and debut JIA under the age of 3 years old -for boys. Also two signs were obtained for predicting remission in girls with JIA it´s early treatment by DMARS and carrier of homogenous genotype containing allele Arg72 gene P53.
Conclusion
In order to predict the nature of the disease and to identify children with risk group of the worst course of JIA is possible to use molecular genetic testing of gene P53 in combination with the study of clinical, instrumental and laboratory data.
